Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
33
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Mohammed Faiz | Interim CFO | 2 | $0 | $0 | 2026-09-01 |
| Corcoran Daniel | SVP and General Counsel | 23 | $0 | $0 | 2026-06-01 |
| Anhalt Rona | Chief Human Resources Officer | 16 | $0 | $0 | 2026-06-01 |
| Bedi Arjun | Director | 4 | $0 | $0 | 2026-05-14 |
| Reynders John V W | Director | 7 | $0 | $0 | 2026-05-14 |
| Killefer Nancy | Director | 14 | $0 | $0 | 2026-05-14 |
| Crane Rosemary A | Director | 12 | $0 | $0 | 2026-05-14 |
| Collins Cynthia | Director | 13 | $0 | $0 | 2026-05-14 |
| WALSH MATTHEW M | Director | 18 | $115.0K | $177.7K | 2026-05-14 |
| BROSHY ERAN | Director | 15 | $79.1K | $0 | 2026-05-14 |
| CASHMAN JAMES E III | Director | 19 | $460.0K | $1.31M | 2026-05-14 |
| Resnick Jon Matthew | Chief Executive Officer | 8 | $0 | $0 | 2026-05-11 |
| Aspbury Robert | President, Simcyp | 63 | $0 | $3.76M | 2026-05-11 |
| Gallagher John E | PRESIDENT, CHIEF COMMERCAL OFF | 35 | $0 | $0 | 2026-05-11 |
| Pedersen Leif E | President, Software | 55 | $0 | $4.45M | 2026-05-11 |
| McKemey Adrian | President, Drug Dev. Solutions | 5 | $0 | $0 | 2026-04-01 |
| Feehery William F | Chief Executive Officer | 59 | $200.0K | $31.78M | 2025-11-11 |
| SMITH PATRICK F | PRESIDENT, INTEGRATED DRUG DEV | 34 | $0 | $1.28M | 2024-10-07 |
| SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICER | 19 | $0 | $0 | 2024-04-01 |
| Traynor Richard M. | SVP and General Counsel | 47 | $5.6K | $6.15M | 2024-04-01 |
| Virkler Drayton | PRESIDENT, REG & ACCES | 10 | $0 | $0 | 2023-04-01 |
| Schemick Michael Andrew | Chief Financial Officer | 18 | $416.0K | $12.56M | 2023-03-31 |
| EQT Fund Management S.a r.l. | 10% Owner | 1 | $0 | $449.32M | 2022-12-08 |
| SLAINE MASON P | Director | 18 | $0 | $50.85M | 2022-11-15 |
| McLean Stephen M. | Director | 2 | $832.4K | $0 | 2022-08-19 |
| EQT Avatar Parent GP LLC | 10% Owner | 3 | $0 | $599.23M | 2022-08-16 |
| EQT Avatar Parent L.P. | 10% Owner | 4 | $0 | $878.39M | 2022-05-31 |
| Edge Justin | See Remarks | 13 | $0 | $1.90M | 2022-04-01 |
| Choe Jieun W. | See Remarks | 13 | $0 | $3.00M | 2022-04-01 |
| Rayner Craig R. | See Remarks | 9 | $0 | $4.78M | 2021-09-02 |
| Gallagher Carol Giltner | Director | 1 | $0 | $0 | 2021-06-15 |
| McCoy Sherilyn S | Director | 1 | $0 | $0 | 2021-05-18 |
| Dickinson Judith | See Remarks | 1 | $0 | $0 | 2021-04-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Mohammed Faiz | Interim CFO | A Award deriv | 2026-09-01 | 2026-09-02 | 63,532 | — | $0 | 63,532 | SEC↗ |
| Mohammed Faiz | Interim CFO | A Award deriv | 2026-09-01 | 2026-09-02 | 63,532 | — | $0 | 63,532 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | M Exercise deriv | 2026-06-01 | 2026-06-02 | 14,889 | — | $0 | 0 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | M Exercise deriv | 2026-06-01 | 2026-06-02 | 7,941 | — | $0 | 7,941 | SEC↗ |
| Anhalt Rona | Chief Human Resources Office | M Exercise deriv | 2026-06-01 | 2026-06-02 | 7,147 | — | $0 | 7,147 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | M Exercise | 2026-06-01 | 2026-06-02 | 14,889 | — | $0 | 39,939 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | F Tax w/h | 2026-06-01 | 2026-06-02 | 4,210 | $5.82 | $24.5K | 25,050 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | M Exercise | 2026-06-01 | 2026-06-02 | 7,941 | — | $0 | 29,260 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | F Tax w/h | 2026-06-01 | 2026-06-02 | 7,893 | $5.82 | $45.9K | 32,046 | SEC↗ |
| Anhalt Rona | Chief Human Resources Office | M Exercise | 2026-06-01 | 2026-06-02 | 7,147 | — | $0 | 19,030 | SEC↗ |
| Anhalt Rona | Chief Human Resources Office | F Tax w/h | 2026-06-01 | 2026-06-02 | 2,241 | $5.82 | $13.0K | 16,789 | SEC↗ |
| WALSH MATTHEW M | Director | A Award deriv | 2026-05-14 | 2026-05-15 | 33,222 | — | $0 | 33,222 | SEC↗ |
| WALSH MATTHEW M | Director | M Exercise deriv | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 0 | SEC↗ |
| Crane Rosemary A | Director | M Exercise deriv | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 0 | SEC↗ |
| Killefer Nancy | Director | A Award deriv | 2026-05-14 | 2026-05-15 | 33,222 | — | $0 | 33,222 | SEC↗ |
| Killefer Nancy | Director | M Exercise deriv | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 0 | SEC↗ |
| CASHMAN JAMES E III | Director | M Exercise deriv | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 0 | SEC↗ |
| CASHMAN JAMES E III | Director | A Award deriv | 2026-05-14 | 2026-05-15 | 33,222 | — | $0 | 33,222 | SEC↗ |
| Bedi Arjun | Director | M Exercise deriv | 2026-05-14 | 2026-05-15 | 5,547 | — | $0 | 0 | SEC↗ |
| Bedi Arjun | Director | A Award deriv | 2026-05-14 | 2026-05-15 | 33,222 | — | $0 | 33,222 | SEC↗ |
| BROSHY ERAN | Director | A Award deriv | 2026-05-14 | 2026-05-15 | 33,222 | — | $0 | 33,222 | SEC↗ |
| BROSHY ERAN | Director | M Exercise deriv | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 0 | SEC↗ |
| Reynders John V W | Chief Financial Officer | M Exercise deriv | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 0 | SEC↗ |
| Reynders John V W | Chief Financial Officer | A Award deriv | 2026-05-14 | 2026-05-15 | 33,222 | — | $0 | 33,222 | SEC↗ |
| Collins Cynthia | Director | M Exercise deriv | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 0 | SEC↗ |
| WALSH MATTHEW M | Director | M Exercise | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 213,316 | SEC↗ |
| Crane Rosemary A | Director | M Exercise | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 45,672 | SEC↗ |
| Killefer Nancy | Director | M Exercise | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 51,846 | SEC↗ |
| CASHMAN JAMES E III | Director | M Exercise | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 484,197 | SEC↗ |
| Bedi Arjun | Director | M Exercise | 2026-05-14 | 2026-05-15 | 5,547 | — | $0 | 5,547 | SEC↗ |
| BROSHY ERAN | Director | M Exercise | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 50,708 | SEC↗ |
| Reynders John V W | Chief Financial Officer | M Exercise | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 26,466 | SEC↗ |
| Collins Cynthia | Director | M Exercise | 2026-05-14 | 2026-05-15 | 15,757 | — | $0 | 51,846 | SEC↗ |
| Gallagher John E | Chief Financial Officer | D To issuer deriv | 2026-05-11 | 2026-05-13 | 102,522 | — | $0 | 0 | SEC↗ |
| Gallagher John E | Chief Financial Officer | A Award deriv | 2026-05-11 | 2026-05-13 | 194,444 | — | $0 | 194,444 | SEC↗ |
| Gallagher John E | Chief Financial Officer | A Award deriv | 2026-05-11 | 2026-05-13 | 102,522 | — | $0 | 102,522 | SEC↗ |
| Gallagher John E | Chief Financial Officer | A Award deriv | 2026-05-11 | 2026-05-13 | 129,629 | — | $0 | 129,629 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | A Award deriv | 2026-05-11 | 2026-05-13 | 111,111 | — | $0 | 111,111 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | A Award deriv | 2026-05-11 | 2026-05-13 | 74,074 | — | $0 | 74,074 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | A Award deriv | 2026-05-11 | 2026-05-13 | 48,820 | — | $0 | 48,820 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | D To issuer deriv | 2026-05-11 | 2026-05-13 | 48,820 | — | $0 | 0 | SEC↗ |
| Resnick Jon Matthew | Chief Executive Officer | A Award deriv | 2026-05-11 | 2026-05-13 | 268,949 | — | $0 | 268,949 | SEC↗ |
| Resnick Jon Matthew | Chief Executive Officer | A Award deriv | 2026-05-11 | 2026-05-13 | 740,740 | — | $0 | 740,740 | SEC↗ |
| Resnick Jon Matthew | Chief Executive Officer | A Award deriv | 2026-05-11 | 2026-05-13 | 179,299 | — | $0 | 179,299 | SEC↗ |
| Resnick Jon Matthew | Chief Executive Officer | A Award deriv | 2026-05-11 | 2026-05-13 | 728,405 | — | $0 | 728,405 | SEC↗ |
| Resnick Jon Matthew | Chief Executive Officer | M Exercise deriv | 2026-05-11 | 2026-05-13 | 59,766 | — | $0 | 119,533 | SEC↗ |
| Resnick Jon Matthew | Chief Executive Officer | A Award deriv | 2026-05-11 | 2026-05-13 | 493,827 | — | $0 | 493,827 | SEC↗ |
| Anhalt Rona | Chief Human Resources Office | A Award deriv | 2026-05-11 | 2026-05-13 | 61,728 | — | $0 | 61,728 | SEC↗ |
| Anhalt Rona | Chief Human Resources Office | A Award deriv | 2026-05-11 | 2026-05-13 | 43,938 | — | $0 | 43,938 | SEC↗ |
| Anhalt Rona | Chief Human Resources Office | D To issuer deriv | 2026-05-11 | 2026-05-13 | 43,938 | — | $0 | 0 | SEC↗ |
| Anhalt Rona | Chief Human Resources Office | A Award deriv | 2026-05-11 | 2026-05-13 | 92,592 | — | $0 | 92,592 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | A Award deriv | 2026-05-11 | 2026-05-13 | 111,111 | — | $0 | 111,111 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | D To issuer deriv | 2026-05-11 | 2026-05-13 | 68,348 | — | $0 | 0 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | A Award deriv | 2026-05-11 | 2026-05-13 | 74,074 | — | $0 | 74,074 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | A Award deriv | 2026-05-11 | 2026-05-13 | 68,348 | — | $0 | 68,348 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | A Award deriv | 2026-05-11 | 2026-05-13 | 129,629 | — | $0 | 129,629 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | A Award deriv | 2026-05-11 | 2026-05-13 | 246,913 | — | $0 | 246,913 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | A Award deriv | 2026-05-11 | 2026-05-13 | 68,348 | — | $0 | 68,348 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | D To issuer deriv | 2026-05-11 | 2026-05-13 | 68,348 | — | $0 | 0 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | A Award deriv | 2026-05-11 | 2026-05-13 | 86,419 | — | $0 | 86,419 | SEC↗ |
| Resnick Jon Matthew | Chief Executive Officer | M Exercise | 2026-05-11 | 2026-05-13 | 59,766 | — | $0 | 59,766 | SEC↗ |
| Resnick Jon Matthew | Chief Executive Officer | F Tax w/h | 2026-05-11 | 2026-05-13 | 24,377 | $6.31 | $153.8K | 35,389 | SEC↗ |
| Anhalt Rona | Chief Human Resources Office | M Exercise deriv | 2026-04-01 | 2026-04-03 | 9,764 | — | $0 | 19,528 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | M Exercise deriv | 2026-04-01 | 2026-04-03 | 10,127 | — | $0 | 10,127 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | M Exercise deriv | 2026-04-01 | 2026-04-03 | 7,852 | — | $0 | 0 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | M Exercise deriv | 2026-04-01 | 2026-04-03 | 15,188 | — | $0 | 30,378 | SEC↗ |
| Gallagher John E | Chief Financial Officer | M Exercise deriv | 2026-04-01 | 2026-04-03 | 22,782 | — | $0 | 45,566 | SEC↗ |
| Gallagher John E | Chief Financial Officer | M Exercise deriv | 2026-04-01 | 2026-04-03 | 15,190 | — | $0 | 15,191 | SEC↗ |
| Gallagher John E | Chief Financial Officer | M Exercise deriv | 2026-04-01 | 2026-04-03 | 12,633 | — | $0 | 0 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | M Exercise deriv | 2026-04-01 | 2026-04-03 | 10,849 | — | $0 | 21,698 | SEC↗ |
| McKemey Adrian | President, Drug Dev. Solutio | M Exercise deriv | 2026-04-01 | 2026-04-03 | 10,849 | — | $0 | 21,698 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | M Exercise deriv | 2026-04-01 | 2026-04-03 | 10,127 | — | $0 | 10,127 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | M Exercise deriv | 2026-04-01 | 2026-04-03 | 15,188 | — | $0 | 30,378 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | M Exercise deriv | 2026-04-01 | 2026-04-03 | 7,852 | — | $0 | 0 | SEC↗ |
| Anhalt Rona | Chief Human Resources Office | M Exercise | 2026-04-01 | 2026-04-03 | 9,764 | — | $0 | 14,945 | SEC↗ |
| Anhalt Rona | Chief Human Resources Office | F Tax w/h | 2026-04-01 | 2026-04-03 | 3,062 | $5.70 | $17.5K | 11,883 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | A Award | 2026-04-01 | 2026-04-03 | 14,510 | — | $0 | 321,686 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | M Exercise | 2026-04-01 | 2026-04-03 | 7,852 | — | $0 | 322,717 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | F Tax w/h | 2026-04-01 | 2026-04-03 | 6,821 | $5.70 | $38.9K | 314,865 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | F Tax w/h | 2026-04-01 | 2026-04-03 | 4,760 | $5.70 | $27.1K | 324,393 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | F Tax w/h | 2026-04-01 | 2026-04-03 | 3,691 | $5.70 | $21.0K | 319,026 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | M Exercise | 2026-04-01 | 2026-04-03 | 10,127 | — | $0 | 329,153 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | F Tax w/h | 2026-04-01 | 2026-04-03 | 7,139 | $5.70 | $40.7K | 332,442 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | M Exercise | 2026-04-01 | 2026-04-03 | 15,188 | — | $0 | 339,581 | SEC↗ |
| Gallagher John E | Chief Financial Officer | F Tax w/h | 2026-04-01 | 2026-04-03 | 7,775 | $5.70 | $44.3K | 62,099 | SEC↗ |
| Gallagher John E | Chief Financial Officer | M Exercise | 2026-04-01 | 2026-04-03 | 12,633 | — | $0 | 74,732 | SEC↗ |
| Gallagher John E | Chief Financial Officer | F Tax w/h | 2026-04-01 | 2026-04-03 | 4,327 | — | $0 | 70,405 | SEC↗ |
| Gallagher John E | Chief Financial Officer | M Exercise | 2026-04-01 | 2026-04-03 | 15,190 | — | $0 | 85,595 | SEC↗ |
| Gallagher John E | Chief Financial Officer | F Tax w/h | 2026-04-01 | 2026-04-03 | 5,203 | $5.70 | $29.7K | 80,392 | SEC↗ |
| Gallagher John E | Chief Financial Officer | M Exercise | 2026-04-01 | 2026-04-03 | 22,782 | — | $0 | 103,174 | SEC↗ |
| Gallagher John E | Chief Financial Officer | F Tax w/h | 2026-04-01 | 2026-04-03 | 7,803 | $5.70 | $44.5K | 95,371 | SEC↗ |
| Gallagher John E | Chief Financial Officer | A Award | 2026-04-01 | 2026-04-03 | 23,346 | — | $0 | 69,874 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | M Exercise | 2026-04-01 | 2026-04-03 | 10,849 | — | $0 | 27,070 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | F Tax w/h | 2026-04-01 | 2026-04-03 | 5,751 | $5.70 | $32.8K | 21,319 | SEC↗ |
| McKemey Adrian | President, Drug Dev. Solutio | F Tax w/h | 2026-04-01 | 2026-04-03 | 2,642 | $5.70 | $15.1K | 8,207 | SEC↗ |
| McKemey Adrian | President, Drug Dev. Solutio | M Exercise | 2026-04-01 | 2026-04-03 | 10,849 | — | $0 | 10,849 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | F Tax w/h | 2026-04-01 | 2026-04-03 | 3,534 | $5.70 | $20.1K | 84,955 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | M Exercise | 2026-04-01 | 2026-04-03 | 10,127 | — | $0 | 101,022 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | M Exercise | 2026-04-01 | 2026-04-03 | 15,188 | — | $0 | 113,744 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | F Tax w/h | 2026-04-01 | 2026-04-03 | 3,699 | $5.70 | $21.1K | 110,045 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | A Award | 2026-04-01 | 2026-04-03 | 14,510 | — | $0 | 88,489 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | F Tax w/h | 2026-04-01 | 2026-04-03 | 2,466 | $5.70 | $14.1K | 98,556 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | M Exercise | 2026-04-01 | 2026-04-03 | 7,852 | — | $0 | 92,807 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | F Tax w/h | 2026-04-01 | 2026-04-03 | 1,912 | $5.70 | $10.9K | 90,895 | SEC↗ |
| Bedi Arjun | Director | A Award deriv | 2026-02-27 | 2026-03-02 | 5,547 | — | $0 | 5,547 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | P Buy | 2025-11-11 | 2025-11-12 | 24,096 | $8.30 | $200.0K | 2,360,769 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | S Sale | 2025-09-09 | 2025-09-11 | 51,224 | $10.92 | $559.4K | 73,979 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | M Exercise deriv | 2025-05-30 | 2025-06-02 | 14,888 | — | $0 | 14,889 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | M Exercise deriv | 2025-05-30 | 2025-06-02 | 7,940 | — | $0 | 15,882 | SEC↗ |
| Anhalt Rona | Chief Human Resources Office | M Exercise deriv | 2025-05-30 | 2025-06-02 | 7,146 | — | $0 | 14,294 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | M Exercise | 2025-05-30 | 2025-06-02 | 7,940 | — | $0 | 7,940 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | F Tax w/h | 2025-05-30 | 2025-06-02 | 2,298 | $11.40 | $26.2K | 5,642 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | M Exercise | 2025-05-30 | 2025-06-02 | 14,888 | — | $0 | 20,530 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | F Tax w/h | 2025-05-30 | 2025-06-02 | 4,309 | $11.40 | $49.1K | 16,221 | SEC↗ |
| Anhalt Rona | Chief Human Resources Office | F Tax w/h | 2025-05-30 | 2025-06-02 | 1,965 | $11.40 | $22.4K | 5,181 | SEC↗ |
| Anhalt Rona | Chief Human Resources Office | M Exercise | 2025-05-30 | 2025-06-02 | 7,146 | — | $0 | 7,146 | SEC↗ |
| BROSHY ERAN | Director | M Exercise deriv | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 0 | SEC↗ |
| BROSHY ERAN | Director | A Award deriv | 2025-05-21 | 2025-05-22 | 15,757 | — | $0 | 15,757 | SEC↗ |
| CASHMAN JAMES E III | Director | A Award deriv | 2025-05-21 | 2025-05-22 | 15,757 | — | $0 | 15,757 | SEC↗ |
| CASHMAN JAMES E III | Director | M Exercise deriv | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 0 | SEC↗ |
| Collins Cynthia | Director | M Exercise deriv | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 0 | SEC↗ |
| Collins Cynthia | Director | A Award deriv | 2025-05-21 | 2025-05-22 | 15,757 | — | $0 | 15,757 | SEC↗ |
| Crane Rosemary A | Director | A Award deriv | 2025-05-21 | 2025-05-22 | 15,757 | — | $0 | 15,757 | SEC↗ |
| Crane Rosemary A | Director | M Exercise deriv | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 0 | SEC↗ |
| Killefer Nancy | Director | A Award deriv | 2025-05-21 | 2025-05-22 | 15,757 | — | $0 | 15,757 | SEC↗ |
| Killefer Nancy | Director | M Exercise deriv | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 0 | SEC↗ |
| Reynders John V W | Director | M Exercise deriv | 2025-05-21 | 2025-05-22 | 10,709 | — | $0 | 0 | SEC↗ |
| Reynders John V W | Director | A Award deriv | 2025-05-21 | 2025-05-22 | 15,757 | — | $0 | 15,757 | SEC↗ |
| WALSH MATTHEW M | Director | A Award deriv | 2025-05-21 | 2025-05-22 | 15,757 | — | $0 | 15,757 | SEC↗ |
| WALSH MATTHEW M | Director | M Exercise deriv | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 0 | SEC↗ |
| BROSHY ERAN | Director | M Exercise | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 34,951 | SEC↗ |
| CASHMAN JAMES E III | Director | M Exercise | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 468,440 | SEC↗ |
| Collins Cynthia | Director | M Exercise | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 36,089 | SEC↗ |
| Crane Rosemary A | Director | M Exercise | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 29,915 | SEC↗ |
| Killefer Nancy | Director | M Exercise | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 36,089 | SEC↗ |
| Reynders John V W | Director | M Exercise | 2025-05-21 | 2025-05-22 | 10,709 | — | $0 | 10,709 | SEC↗ |
| WALSH MATTHEW M | Director | M Exercise | 2025-05-21 | 2025-05-22 | 11,928 | — | $0 | 197,559 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-05-20 | 2025-05-22 | 187,144 | — | $0 | 187,144 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | A Award deriv | 2025-05-20 | 2025-05-22 | 280,716 | — | $0 | 280,716 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | A Award deriv | 2025-05-20 | 2025-05-22 | 68,348 | — | $0 | 68,348 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | A Award deriv | 2025-05-20 | 2025-05-22 | 45,566 | — | $0 | 45,566 | SEC↗ |
| Gallagher John E | Chief Financial Officer | A Award deriv | 2025-05-20 | 2025-05-22 | 102,522 | — | $0 | 102,522 | SEC↗ |
| Gallagher John E | Chief Financial Officer | A Award deriv | 2025-05-20 | 2025-05-22 | 68,348 | — | $0 | 68,348 | SEC↗ |
| McKemey Adrian | President, Drug Dev. Solutio | A Award deriv | 2025-05-20 | 2025-05-22 | 48,820 | — | $0 | 48,820 | SEC↗ |
| McKemey Adrian | President, Drug Dev. Solutio | A Award deriv | 2025-05-20 | 2025-05-22 | 32,547 | — | $0 | 32,547 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | A Award deriv | 2025-05-20 | 2025-05-22 | 68,348 | — | $0 | 68,348 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | A Award deriv | 2025-05-20 | 2025-05-22 | 45,566 | — | $0 | 45,566 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | A Award deriv | 2025-05-20 | 2025-05-22 | 48,820 | — | $0 | 48,820 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | A Award deriv | 2025-05-20 | 2025-05-22 | 32,547 | — | $0 | 32,547 | SEC↗ |
| Anhalt Rona | Chief Human Resources Office | A Award deriv | 2025-05-20 | 2025-05-22 | 43,938 | — | $0 | 43,938 | SEC↗ |
| Anhalt Rona | Chief Human Resources Office | A Award deriv | 2025-05-20 | 2025-05-22 | 29,292 | — | $0 | 29,292 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2025-04-01 | 2025-04-03 | 41,593 | — | $0 | 83,186 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2025-04-01 | 2025-04-03 | 33,220 | — | $0 | 33,220 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2025-04-01 | 2025-04-03 | 36,580 | — | $0 | 0 | SEC↗ |
| Gallagher John E | PRESIDENT, CHIEF COMMERCAL O | M Exercise deriv | 2025-04-01 | 2025-04-03 | 12,633 | — | $0 | 12,633 | SEC↗ |
| Gallagher John E | PRESIDENT, CHIEF COMMERCAL O | M Exercise deriv | 2025-04-01 | 2025-04-03 | 14,663 | — | $0 | 0 | SEC↗ |
| Gallagher John E | PRESIDENT, CHIEF COMMERCAL O | M Exercise deriv | 2025-04-01 | 2025-04-03 | 15,190 | — | $0 | 30,381 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | M Exercise deriv | 2025-04-01 | 2025-04-03 | 8,647 | — | $0 | 0 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | M Exercise deriv | 2025-04-01 | 2025-04-03 | 10,127 | — | $0 | 20,254 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | M Exercise deriv | 2025-04-01 | 2025-04-03 | 7,852 | — | $0 | 7,852 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | M Exercise deriv | 2025-04-01 | 2025-04-03 | 7,852 | — | $0 | 7,852 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | M Exercise deriv | 2025-04-01 | 2025-04-03 | 10,127 | — | $0 | 20,254 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | M Exercise deriv | 2025-04-01 | 2025-04-03 | 8,647 | — | $0 | 0 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2025-04-01 | 2025-04-03 | 8,238 | $9.90 | $81.6K | 2,270,876 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | A Award | 2025-04-01 | 2025-04-03 | 29,960 | — | $0 | 2,279,114 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | M Exercise | 2025-04-01 | 2025-04-03 | 36,580 | — | $0 | 2,307,456 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2025-04-01 | 2025-04-03 | 13,807 | $9.90 | $136.7K | 2,293,649 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | M Exercise | 2025-04-01 | 2025-04-03 | 33,220 | — | $0 | 2,326,869 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2025-04-01 | 2025-04-03 | 14,116 | $9.90 | $139.7K | 2,312,753 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | M Exercise | 2025-04-01 | 2025-04-03 | 41,593 | — | $0 | 2,354,346 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2025-04-01 | 2025-04-03 | 17,673 | $9.90 | $175.0K | 2,336,673 | SEC↗ |
| Gallagher John E | PRESIDENT, CHIEF COMMERCAL O | M Exercise | 2025-04-01 | 2025-04-03 | 15,190 | — | $0 | 51,731 | SEC↗ |
| Gallagher John E | PRESIDENT, CHIEF COMMERCAL O | M Exercise | 2025-04-01 | 2025-04-03 | 14,663 | — | $0 | 32,881 | SEC↗ |
| Gallagher John E | PRESIDENT, CHIEF COMMERCAL O | F Tax w/h | 2025-04-01 | 2025-04-03 | 5,203 | $9.90 | $51.5K | 46,528 | SEC↗ |
| Gallagher John E | PRESIDENT, CHIEF COMMERCAL O | F Tax w/h | 2025-04-01 | 2025-04-03 | 4,327 | $9.90 | $42.8K | 36,541 | SEC↗ |
| Gallagher John E | PRESIDENT, CHIEF COMMERCAL O | F Tax w/h | 2025-04-01 | 2025-04-03 | 4,646 | $9.90 | $46.0K | 28,235 | SEC↗ |
| Gallagher John E | PRESIDENT, CHIEF COMMERCAL O | M Exercise | 2025-04-01 | 2025-04-03 | 12,633 | — | $0 | 40,868 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | M Exercise | 2025-04-01 | 2025-04-03 | 8,647 | — | $0 | 113,708 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | F Tax w/h | 2025-04-01 | 2025-04-03 | 2,466 | $9.90 | $24.4K | 125,203 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | F Tax w/h | 2025-04-01 | 2025-04-03 | 1,912 | $9.90 | $18.9K | 117,542 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | M Exercise | 2025-04-01 | 2025-04-03 | 7,852 | — | $0 | 119,454 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | F Tax w/h | 2025-04-01 | 2025-04-03 | 2,106 | $9.90 | $20.8K | 111,602 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | M Exercise | 2025-04-01 | 2025-04-03 | 10,127 | — | $0 | 127,669 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | F Tax w/h | 2025-04-01 | 2025-04-03 | 1,725 | $9.90 | $17.1K | 105,061 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | A Award | 2025-04-01 | 2025-04-03 | 7,082 | — | $0 | 106,786 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | F Tax w/h | 2025-04-01 | 2025-04-03 | 4,065 | $9.90 | $40.2K | 297,648 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | M Exercise | 2025-04-01 | 2025-04-03 | 8,647 | — | $0 | 301,713 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | F Tax w/h | 2025-04-01 | 2025-04-03 | 3,330 | $9.90 | $33.0K | 293,066 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | F Tax w/h | 2025-04-01 | 2025-04-03 | 4,760 | $9.90 | $47.1K | 307,176 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | M Exercise | 2025-04-01 | 2025-04-03 | 7,852 | — | $0 | 305,500 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | F Tax w/h | 2025-04-01 | 2025-04-03 | 3,691 | $9.90 | $36.5K | 301,809 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | M Exercise | 2025-04-01 | 2025-04-03 | 10,127 | — | $0 | 311,936 | SEC↗ |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH | A Award | 2025-04-01 | 2025-04-03 | 7,082 | — | $0 | 296,396 | SEC↗ |
| Reynders John V W | Director | A Award deriv | 2024-10-16 | 2024-10-18 | 10,709 | — | $0 | 10,709 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | S Sale | 2024-10-07 | 2024-10-08 | 5,409 | $11.03 | $59.7K | 50,091 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | M Exercise deriv | 2024-10-04 | 2024-10-07 | 7,151 | — | $0 | 14,303 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | F Tax w/h | 2024-10-04 | 2024-10-07 | 1,742 | $10.99 | $19.1K | 55,500 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | M Exercise | 2024-10-04 | 2024-10-07 | 7,151 | — | $0 | 57,242 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | S Sale | 2024-09-09 | 2024-09-10 | 51,224 | $11.29 | $578.3K | 99,704 | SEC↗ |
| Aspbury Robert | PRESIDENT, SCIENTIFIC SOFTWA | F Tax w/h | 2024-07-01 | 2024-07-02 | 862 | $13.85 | $11.9K | 289,314 | SEC↗ |
| Anhalt Rona | Chief Human Resources Office | A Award deriv | 2024-06-01 | 2024-06-03 | 21,440 | — | $0 | 21,440 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | A Award deriv | 2024-06-01 | 2024-06-03 | 23,822 | — | $0 | 23,822 | SEC↗ |
| Corcoran Daniel | SVP and General Counsel | A Award deriv | 2024-06-01 | 2024-06-03 | 29,777 | — | $0 | 29,777 | SEC↗ |
| BROSHY ERAN | Director | A Award deriv | 2024-05-21 | 2024-05-23 | 11,928 | — | $0 | 11,928 | SEC↗ |
| BROSHY ERAN | Director | M Exercise deriv | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 0 | SEC↗ |
| CASHMAN JAMES E III | Director | A Award deriv | 2024-05-21 | 2024-05-23 | 11,928 | — | $0 | 11,928 | SEC↗ |
| CASHMAN JAMES E III | Director | M Exercise deriv | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 0 | SEC↗ |
| Collins Cynthia | Director | M Exercise deriv | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 0 | SEC↗ |
| Collins Cynthia | Director | A Award deriv | 2024-05-21 | 2024-05-23 | 11,928 | — | $0 | 11,928 | SEC↗ |
| Crane Rosemary A | Director | M Exercise deriv | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 0 | SEC↗ |
| Crane Rosemary A | Director | A Award deriv | 2024-05-21 | 2024-05-23 | 11,928 | — | $0 | 11,928 | SEC↗ |
| Killefer Nancy | Director | A Award deriv | 2024-05-21 | 2024-05-23 | 11,928 | — | $0 | 11,928 | SEC↗ |
| Killefer Nancy | Director | M Exercise deriv | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 0 | SEC↗ |
| WALSH MATTHEW M | Director | A Award deriv | 2024-05-21 | 2024-05-23 | 11,928 | — | $0 | 11,928 | SEC↗ |
| WALSH MATTHEW M | Director | M Exercise deriv | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 0 | SEC↗ |
| BROSHY ERAN | Director | M Exercise | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 23,023 | SEC↗ |
| CASHMAN JAMES E III | Director | M Exercise | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 456,512 | SEC↗ |
| Collins Cynthia | Director | M Exercise | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 24,161 | SEC↗ |
| Crane Rosemary A | Director | M Exercise | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 17,987 | SEC↗ |
| Killefer Nancy | Director | M Exercise | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 24,161 | SEC↗ |
| WALSH MATTHEW M | Director | M Exercise | 2024-05-21 | 2024-05-23 | 8,663 | — | $0 | 185,631 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | S Sale | 2024-04-02 | 2024-04-04 | 5,264 | $16.76 | $88.2K | 59,254 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | S Sale | 2024-04-02 | 2024-04-04 | 649 | $17.72 | $11.5K | 58,605 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | S Sale | 2024-04-02 | 2024-04-04 | 3,024 | $16.75 | $50.7K | 55,581 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | S Sale | 2024-04-02 | 2024-04-04 | 328 | $17.67 | $5.8K | 55,253 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | S Sale | 2024-04-02 | 2024-04-04 | 4,740 | $16.77 | $79.5K | 50,513 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | S Sale | 2024-04-02 | 2024-04-04 | 422 | $17.77 | $7.5K | 50,091 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2024-04-01 | 2024-04-03 | 36,580 | — | $0 | 36,580 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2024-04-01 | 2024-04-03 | 33,219 | — | $0 | 66,440 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | A Award deriv | 2024-04-01 | 2024-04-03 | 120,981 | — | $0 | 120,981 | SEC↗ |
| Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWA | A Award deriv | 2024-04-01 | 2024-04-03 | 30,381 | — | $0 | 30,381 | SEC↗ |
| Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWA | M Exercise deriv | 2024-04-01 | 2024-04-03 | 8,646 | — | $0 | 8,647 | SEC↗ |
| Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWA | M Exercise deriv | 2024-04-01 | 2024-04-03 | 7,852 | — | $0 | 15,704 | SEC↗ |
| Gallagher John E | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2024-04-01 | 2024-04-03 | 12,632 | — | $0 | 25,266 | SEC↗ |
| Gallagher John E | CHIEF FINANCIAL OFFICER | M Exercise deriv | 2024-04-01 | 2024-04-03 | 14,663 | — | $0 | 14,663 | SEC↗ |
| Gallagher John E | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-04-01 | 2024-04-03 | 45,571 | — | $0 | 45,571 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | A Award deriv | 2024-04-01 | 2024-04-03 | 30,381 | — | $0 | 30,381 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | M Exercise deriv | 2024-04-01 | 2024-04-03 | 7,852 | — | $0 | 15,704 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | M Exercise deriv | 2024-04-01 | 2024-04-03 | 8,646 | — | $0 | 8,647 | SEC↗ |
| SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICE | M Exercise deriv | 2024-04-01 | 2024-04-03 | 4,228 | — | $0 | 8,456 | SEC↗ |
| SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICE | M Exercise deriv | 2024-04-01 | 2024-04-03 | 3,991 | — | $0 | 3,991 | SEC↗ |
| SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICE | A Award deriv | 2024-04-01 | 2024-04-03 | 15,190 | — | $0 | 15,190 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | A Award deriv | 2024-04-01 | 2024-04-03 | 30,381 | — | $0 | 30,381 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | M Exercise deriv | 2024-04-01 | 2024-04-03 | 8,646 | — | $0 | 8,647 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | M Exercise deriv | 2024-04-01 | 2024-04-03 | 7,852 | — | $0 | 15,704 | SEC↗ |
| Traynor Richard M. | SVP AND GENERAL COUNSEL | M Exercise deriv | 2024-04-01 | 2024-04-03 | 6,644 | — | $0 | 13,288 | SEC↗ |
| Traynor Richard M. | SVP AND GENERAL COUNSEL | M Exercise deriv | 2024-04-01 | 2024-04-03 | 6,651 | — | $0 | 6,651 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | A Award deriv | 2024-04-01 | 2024-04-05 | 124,779 | — | $0 | 124,779 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2024-04-01 | 2024-04-03 | 15,543 | $17.88 | $277.9K | 2,230,050 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2024-04-01 | 2024-04-03 | 14,115 | $17.88 | $252.4K | 2,249,154 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | M Exercise | 2024-04-01 | 2024-04-03 | 36,580 | — | $0 | 2,245,593 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2024-04-01 | 2024-04-03 | 12,971 | $17.88 | $231.9K | 2,209,013 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | M Exercise | 2024-04-01 | 2024-04-03 | 33,219 | — | $0 | 2,263,269 | SEC↗ |
| Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWA | M Exercise | 2024-04-01 | 2024-04-03 | 8,646 | — | $0 | 290,079 | SEC↗ |
| Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWA | F Tax w/h | 2024-04-01 | 2024-04-03 | 4,064 | $17.88 | $72.7K | 286,015 | SEC↗ |
| Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWA | M Exercise | 2024-04-01 | 2024-04-03 | 7,852 | — | $0 | 293,867 | SEC↗ |
| Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWA | F Tax w/h | 2024-04-01 | 2024-04-03 | 3,691 | $17.88 | $66.0K | 290,176 | SEC↗ |
| Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWA | F Tax w/h | 2024-04-01 | 2024-04-03 | 2,870 | $17.88 | $51.3K | 281,433 | SEC↗ |
| Gallagher John E | CHIEF FINANCIAL OFFICER | M Exercise | 2024-04-01 | 2024-04-03 | 14,663 | — | $0 | 14,663 | SEC↗ |
| Gallagher John E | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-04-01 | 2024-04-03 | 4,750 | $17.88 | $84.9K | 9,913 | SEC↗ |
| Gallagher John E | CHIEF FINANCIAL OFFICER | M Exercise | 2024-04-01 | 2024-04-03 | 12,632 | — | $0 | 22,545 | SEC↗ |
| Gallagher John E | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-04-01 | 2024-04-03 | 4,327 | $17.88 | $77.4K | 18,218 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | M Exercise | 2024-04-01 | 2024-04-03 | 7,852 | — | $0 | 152,840 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | M Exercise | 2024-04-01 | 2024-04-03 | 8,646 | — | $0 | 147,094 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | F Tax w/h | 2024-04-01 | 2024-04-03 | 1,912 | $17.88 | $34.2K | 150,928 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | F Tax w/h | 2024-04-01 | 2024-04-03 | 2,106 | $17.88 | $37.7K | 144,988 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | F Tax w/h | 2024-04-01 | 2024-04-03 | 1,933 | $17.88 | $34.6K | 138,448 | SEC↗ |
| SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICE | M Exercise | 2024-04-01 | 2024-04-03 | 4,228 | — | $0 | 25,684 | SEC↗ |
| SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICE | F Tax w/h | 2024-04-01 | 2024-04-03 | 1,326 | $17.88 | $23.7K | 24,358 | SEC↗ |
| SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICE | M Exercise | 2024-04-01 | 2024-04-03 | 3,991 | — | $0 | 22,708 | SEC↗ |
| SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICE | F Tax w/h | 2024-04-01 | 2024-04-03 | 1,252 | $17.88 | $22.4K | 21,456 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | F Tax w/h | 2024-04-01 | 2024-04-03 | 2,690 | $17.88 | $48.1K | 64,518 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | M Exercise | 2024-04-01 | 2024-04-03 | 8,646 | — | $0 | 62,089 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | F Tax w/h | 2024-04-01 | 2024-04-03 | 1,532 | $17.88 | $27.4K | 53,443 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | M Exercise | 2024-04-01 | 2024-04-03 | 7,852 | — | $0 | 67,208 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | F Tax w/h | 2024-04-01 | 2024-04-03 | 2,733 | $17.88 | $48.9K | 59,356 | SEC↗ |
| Traynor Richard M. | SVP AND GENERAL COUNSEL | M Exercise | 2024-04-01 | 2024-04-03 | 6,644 | — | $0 | 178,800 | SEC↗ |
| Traynor Richard M. | SVP AND GENERAL COUNSEL | S Sale | 2024-04-01 | 2024-04-03 | 3,000 | $18.00 | $54.0K | 173,524 | SEC↗ |
| Traynor Richard M. | SVP AND GENERAL COUNSEL | F Tax w/h | 2024-04-01 | 2024-04-03 | 1,723 | $17.88 | $30.8K | 167,750 | SEC↗ |
| Traynor Richard M. | SVP AND GENERAL COUNSEL | F Tax w/h | 2024-04-01 | 2024-04-03 | 2,276 | $17.88 | $40.7K | 176,524 | SEC↗ |
| Traynor Richard M. | SVP AND GENERAL COUNSEL | M Exercise | 2024-04-01 | 2024-04-03 | 6,651 | — | $0 | 174,401 | SEC↗ |
| Traynor Richard M. | SVP AND GENERAL COUNSEL | F Tax w/h | 2024-04-01 | 2024-04-03 | 2,245 | $17.88 | $40.1K | 172,156 | SEC↗ |
| Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWA | A Award | 2024-03-05 | 2024-03-06 | 3,589 | — | $0 | 285,992 | SEC↗ |
| Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWA | F Tax w/h | 2024-03-05 | 2024-03-06 | 1,689 | $18.88 | $31.9K | 284,303 | SEC↗ |
| Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWA | F Tax w/h | 2024-03-05 | 2024-03-06 | 5,622 | $18.88 | $106.1K | 282,403 | SEC↗ |
| Aspbury Robert | PRESIDENT; SCIENTIFIC SOFTWA | A Award | 2024-03-05 | 2024-03-06 | 11,960 | — | $0 | 288,025 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | F Tax w/h | 2024-03-05 | 2024-03-06 | 17,557 | $18.88 | $331.5K | 2,221,984 | SEC↗ |
| Feehery William F | CHIEF EXECUTIVE OFFICER | A Award | 2024-03-05 | 2024-03-06 | 59,799 | — | $0 | 2,239,541 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | F Tax w/h | 2024-03-05 | 2024-03-06 | 4,050 | $18.88 | $76.5K | 140,381 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | A Award | 2024-03-05 | 2024-03-06 | 15,548 | — | $0 | 144,431 | SEC↗ |
| SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICE | A Award | 2024-03-05 | 2024-03-06 | 6,600 | — | $0 | 21,090 | SEC↗ |
| SHERMAN NICOLETTE D | CHIEF HUMAN RESOURCES OFFICE | F Tax w/h | 2024-03-05 | 2024-03-06 | 2,373 | $18.88 | $44.8K | 18,717 | SEC↗ |
| Traynor Richard M. | SVP AND GENERAL COUNSEL | F Tax w/h | 2024-03-05 | 2024-03-06 | 3,660 | $18.88 | $69.1K | 169,473 | SEC↗ |
| Traynor Richard M. | SVP AND GENERAL COUNSEL | A Award | 2024-03-05 | 2024-03-06 | 10,765 | — | $0 | 173,133 | SEC↗ |
| Traynor Richard M. | SVP AND GENERAL COUNSEL | S Sale | 2024-03-04 | 2024-03-05 | 3,000 | $18.28 | $54.8K | 162,368 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | S Sale | 2024-02-20 | 2024-02-21 | 5,000 | $18.00 | $90.0K | 54,975 | SEC↗ |
| Traynor Richard M. | SVP AND GENERAL COUNSEL | S Sale | 2024-02-12 | 2024-02-14 | 6,000 | $18.00 | $108.0K | 165,368 | SEC↗ |
| Traynor Richard M. | SVP AND GENERAL COUNSEL | S Sale | 2023-12-26 | 2023-12-27 | 6,000 | $18.00 | $108.0K | 171,368 | SEC↗ |
| SMITH PATRICK F | PRESIDENT, DRUG DEV SOLUTION | A Award deriv | 2023-10-05 | 2023-10-06 | 21,454 | — | $0 | 21,454 | SEC↗ |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL O | S Sale | 2023-09-11 | 2023-09-12 | 51,224 | $14.60 | $747.9K | 128,883 | SEC↗ |